According to Onconova Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.87. In 2014 the company made an earnings per share (EPS) of -$6,637 an increase over its 2013 EPS that were of -$8,189.
Year | EPS | Change |
---|---|---|
2022 (TTM) | -$0.87 | |
2014 | -$6,637 | -18.95% |
2013 | -$8,189 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Baxter BAX | -$4.83 | 455.17% | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | -$0.64 | -26.44% | ๐บ๐ธ USA |
![]() CTI BioPharma
CTIC | -$0.85 | -2.30% | ๐บ๐ธ USA |
![]() Array Technologies ARRY | -$0.39 | -55.17% | ๐บ๐ธ USA |